Syncom Formulation (India) Share Price
₹19.86 +0.05 (0.25%)
28 Dec, 2024 02:24
Start SIP in SYNCOMF
Start SIPPerformance
- Low
- ₹20
- High
- ₹20
- 52 Week Low
- ₹11
- 52 Week High
- ₹28
- Open Price₹20
- Previous Close₹20
- Volume2,170,324
Investment Returns
- Over 1 Month + 1.02%
- Over 3 Month -6.85%
- Over 6 Month + 57.87%
- Over 1 Year + 40.55%
Smart Investing Starts Here Start SIP with Syncom Formulation (India) for Steady Growth!
Syncom Formulation (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.3
- PEG Ratio
- 1.4
- Market Cap Cr
- 1,867
- P/B Ratio
- 6.5
- Average True Range
- 0.81
- EPS
- 0.35
- Dividend Yield
- 0
- MACD Signal
- 0.06
- RSI
- 38.8
- MFI
- 18.43
Syncom Formulation (India) Financials
Syncom Formulation (India) Technicals
EMA & SMA
Current Price
₹19.86
+
0.05
(0.25%)
- Bullish Moving Average 0
- Bearish Moving Average 0
- 20 Day
- ₹20.89
- 50 Day
- ₹20.79
- 100 Day
- ₹19.86
- 200 Day
- ₹17.80
Resistance and Support
19.86
- R3 20.47
- R2 20.27
- R1 20.06
- S1 19.65
- S2 19.45
- S3 19.24
Syncom Formulation (India) Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-05-17 | Audited Results | |
2024-02-14 | Quarterly Results | |
2023-11-08 | Quarterly Results |
Syncom Formulation (India) F&O
About Syncom Formulation (India)
- NSE Symbol
- SYNCOMF
- BSE Symbol
- 524470
- Managing Director
- Mr. Vijay Shankarlal Bankda
- ISIN
- INE312C01025
Similar Stocks to Syncom Formulation (India)
Syncom Formulation (India) FAQs
Syncom Formulation (India) share price is ₹19 As on 28 December, 2024 | 02:10
The Market Cap of Syncom Formulation (India) is ₹1866.8 Cr As on 28 December, 2024 | 02:10
The P/E ratio of Syncom Formulation (India) is 56.3 As on 28 December, 2024 | 02:10
The PB ratio of Syncom Formulation (India) is 6.5 As on 28 December, 2024 | 02:10
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.